Abstract
Background: De-escalation of axillary surgery following neoadjuvant chemotherapy (NACT) for patients with node positive disease at diagnosis have focused on ensuring a low false negative rate for those who undergo sentinel lymph node biopsy (SLNB) only. Histopathological evidence of treatment effect is one surrogate that supports an axillary pathological complete response (pCR). This study aimed to assess rates of histological treatment effect in patients who have an axillary pCR following axillary surgery post NACT.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
